These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 7539977)
1. Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis. Estrov Z; Talpaz M; Mavligit G; Pazdur R; Harris D; Greenberg SM; Kurzrock R Am J Med; 1995 Jun; 98(6):551-8. PubMed ID: 7539977 [TBL] [Abstract][Full Text] [Related]
2. Thrombocytosis in patients with tumors producing colony-stimulating factor. Suzuki A; Takahashi T; Nakamura K; Tsuyuoka R; Okuno Y; Enomoto T; Fukumoto M; Imura H Blood; 1992 Oct; 80(8):2052-9. PubMed ID: 1382717 [TBL] [Abstract][Full Text] [Related]
3. Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-hodgkin's lymphoma undergoing cytoreductive chemotherapy. Reisbach G; Kamp T; Welzl G; Geiz C; Abedinpour Fariborz ; Lodri A; Kaboth W; Dörmer P; Nerl C Br J Haematol; 1996 Mar; 92(4):907-12. PubMed ID: 8616084 [TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis. Uppenkamp M; Makarova E; Petrasch S; Brittinger G Ann Hematol; 1998 Nov; 77(5):217-23. PubMed ID: 9858147 [TBL] [Abstract][Full Text] [Related]
5. Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis. Hsu HC; Tsai WH; Jiang ML; Ho CH; Hsu ML; Ho CK; Wang SY J Lab Clin Med; 1999 Oct; 134(4):392-7. PubMed ID: 10521086 [TBL] [Abstract][Full Text] [Related]
6. Granulocyte and granulocyte-macrophage colony-stimulating factors, their receptors and interleukin-3 levels in newborns. Coşkun M; Kardelen F; Oygür N; Undar L; Savaş A; Yeğin O Turk J Pediatr; 1997; 39(3):295-301. PubMed ID: 9339107 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autografts. Kawano Y; Takaue Y; Saito S; Sato J; Shimizu T; Suzue T; Hirao A; Okamoto Y; Abe T; Watanabe T Blood; 1993 Feb; 81(3):856-60. PubMed ID: 7679001 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 beta (IL-1 beta) induces thrombocytosis in mice: possible implication of IL-6. Kimura H; Ishibashi T; Shikama Y; Okano A; Akiyama Y; Uchida T; Maruyama Y Blood; 1990 Dec; 76(12):2493-500. PubMed ID: 2265245 [TBL] [Abstract][Full Text] [Related]
9. Synchronous fluctuation of interleukin-6 and platelet count in cyclic thrombocytopenia and thrombocytosis. Kuyama J; Take H; Matsumoto S; Nakajima T; Sugase T; Hata A; Hanada M; Nakagawa K Intern Med; 1995 Jul; 34(7):636-9. PubMed ID: 7496073 [TBL] [Abstract][Full Text] [Related]
10. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients]. Ławicki S; Czygier M; Omyła J; Bedkowska E; Szmitkowski M Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847 [TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma. Wetzler M; Estrov Z; Talpaz M; Markowitz A; Gutterman JU; Kurzrock R J Intern Med; 1993 Oct; 234(4):417-20. PubMed ID: 7691980 [TBL] [Abstract][Full Text] [Related]
12. [Selected hematopoietic cytokines in patients with colorectal cancer]. Mroczko B; Ławicki S; Szmitkowski M; Czygier M; Okulczyk B; Piotrowski Z Pol Merkur Lekarski; 2003 Nov; 15(89):416-9. PubMed ID: 14969133 [TBL] [Abstract][Full Text] [Related]
13. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients. Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163 [TBL] [Abstract][Full Text] [Related]
14. Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Verhoef GE; De Schouwer P; Ceuppens JL; Van Damme J; Goossens W; Boogaerts MA Leukemia; 1992 Dec; 6(12):1268-72. PubMed ID: 1280751 [TBL] [Abstract][Full Text] [Related]
15. Recombinant human granulocyte-macrophage colony-stimulating factor therapy and endogenous plasma GM-CSF, IL-3, IL-4 concentrations in pediatric patients with solid tumors. Cetingül N; Kütükçüler N; Kantar M; Kavakli K; Nişli G; Cağlayan S; Oztop S Turk J Pediatr; 1997; 39(4):473-81. PubMed ID: 9433149 [TBL] [Abstract][Full Text] [Related]
17. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer]. Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M Przegl Lek; 2009; 66(7):365-9. PubMed ID: 20043577 [TBL] [Abstract][Full Text] [Related]
18. The induction of interleukin-6 (IL-6) and colony-stimulating factors (CSFs) by FK565 and its thrombopoietic activity following in vivo administration. Maeda M; Suzuki S; Ohtsuka K; Satoh S; Nishigaki F; Shimomura K; Imai Y; Niwa M; Kohsaka M Biol Pharm Bull; 1994 Feb; 17(2):173-9. PubMed ID: 7515742 [TBL] [Abstract][Full Text] [Related]